Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

STENTYS announces European commercial release of new Self-Apposing stent technology

STENTYS, a medical technology company commercializing the world's first and only self-apposing stent to treat Acute Myocardial Infarction (AMI), announced today the European commercial release of an enhanced stent-delivery system for its Self-Apposing stent.

27 Sep 2012

Enrollment complete in Resverlogix‘s RVX-208 Phase 2b trial on cardiovascular disease

Resverlogix Corp. today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial targeting high-risk cardiovascular disease patients.

27 Sep 2012

GSK3 inhibition protects against gum disease

Treatment with the cell-permeable glycogen synthase kinase -3β-specific enzyme inhibitor SB216763 successfully suppresses alveolar bone loss in mice infected with the main periodontal pathogen, Porphyromonas gingivalis, report researchers.

20 Sep 2012

FDA Division of Neurology Products, CoLucid reach agreement for lasmiditan development strategy

CoLucid Pharmaceuticals, Inc., a privately held biopharmaceutical company, has reached agreement with the Food and Drug Administration's Division of Neurology Products concerning the development strategy for lasmiditan at a recently completed End of Phase 2 meeting.

19 Sep 2012

Dabigatran increasingly being used off-label

Dabigatran has increasingly been used for off-label indications, including venous thromboembolism, in the USA between 2007 and 2011, a study suggests.

13 Sep 2012

Silent infarcts prognostic in young stroke patients

Silent ischemic lesions are common and are associated with a high rate of recurrent events in young patients with acute ischemic stroke, report researchers.

12 Sep 2012

Exercise and health: An interview with Professor Karim Khan

I’ll quote from the ‘7 investments’ document (see below) as I don’t believe we need to reinvent the wheel to argue for the benefits of exercise. I am very keen to move to the issue of ‘how can we help people exercise’. But for the record:

12 Sep 2012

Baylor Health Care System raises awareness about atrial fibrillation

An estimated 2.5 million Americans suffer from irregular heartbeats-also known as atrial fibrillation. Baylor Health Care System is raising awareness about this often misunderstood, but potentially life changing cardiovascular condition whose incidence is on the rise and expected to more than double by 2050.

10 Sep 2012

CAD risk no higher in head and neck cancer

Researchers have shown that people with head or neck cancer are not necessarily at any greater risk for developing coronary artery disease than the general population.

4 Sep 2012

Tunes and T-shirts for cardiac rehabilitation

Two studies presented at the European Society of Cardiology Congress in Munich, Germany, showed how researchers are developing innovative approaches to help patients get the most out of cardiac rehabilitation.

31 Aug 2012

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

A study published in the most recent issue of the Journal of the American Medical Association (JAMA) presented encouraging news regarding physicians' ability to determine blood flow and associated coronary artery disease (CAD) using noninvasive CT scanning technology.

30 Aug 2012

Tunes and T-shirts for cardiac rehabilitation

29 Aug 2012

Mortality risk similar for White vs Black diabetics

Diabetes does not lead to an intrinsically poorer survival in African Americans than it does in White Americans, report US researchers.

29 Aug 2012

Study finds decline in 30-day mortality of acute myocardial infarction with improved treatment

Improved treatment after acute myocardial infarction and less severe patient profile have reduced 30-day mortality over the past 15 years, according to research presented at ESC Congress 2012.

29 Aug 2012

FFR-guided PCI plus medical therapy reduce need for urgent revascularization in CAD patients

Patients with stable coronary artery disease (CAD) had a lower need for urgent revascularisation when receiving fractional flow reserve (FFR)-guided PCI plus the best available medical therapy (MT) than when receiving MT alone. The results, from a final analysis of the FAME 2 trial, were presented today during a Hot Line session of ESC Congress 2012 in Munich.

29 Aug 2012

Addition of CTP to CT angiography allows clinicians to identify flow-limiting coronary artery disease

A non-invasive imaging strategy which integrates non-invasive CT angiography (CTA) and CT myocardial perfusion imaging (CTP) has robust diagnostic accuracy for identifying patients with flow-limiting coronary artery disease in need of myocardial revascularisation, according to results of the CORE320 study presented here today by Dr Joao AC Lima from Johns Hopkins Hospital, Baltimore, USA.

29 Aug 2012

Elixir Medical’s DESyne BD Novolimus Eluting Coronary Stent System receives CE Mark approval

Elixir Medical Corporation, a developer of product platforms that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE Mark approval for its DESyne BD Novolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

29 Aug 2012

Resuming smoking after stroke can increase risk of mortality

Patients who resume smoking after a stroke increase their risk of death by three-fold, according to research presented at ESC Congress 2012 by Professor Furio Colivicchi from San Filippo Neri Hospital.

28 Aug 2012

CardioDx completes two-tranche equity financing

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced the completion of a $58 million two-tranche equity financing.

27 Aug 2012

Study explores gender-related differences in patients hospitalized for acute heart failure

Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.

27 Aug 2012

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

STENTYS announces European commercial release of new Self-Apposing stent technology

Enrollment complete in Resverlogix‘s RVX-208 Phase 2b trial on cardiovascular disease

GSK3 inhibition protects against gum disease

FDA Division of Neurology Products, CoLucid reach agreement for lasmiditan development strategy

Dabigatran increasingly being used off-label

Silent infarcts prognostic in young stroke patients

Exercise and health: An interview with Professor Karim Khan

Baylor Health Care System raises awareness about atrial fibrillation

CAD risk no higher in head and neck cancer

Tunes and T-shirts for cardiac rehabilitation

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

Tunes and T-shirts for cardiac rehabilitation

Mortality risk similar for White vs Black diabetics

Study finds decline in 30-day mortality of acute myocardial infarction with improved treatment

FFR-guided PCI plus medical therapy reduce need for urgent revascularization in CAD patients

Addition of CTP to CT angiography allows clinicians to identify flow-limiting coronary artery disease

Elixir Medical’s DESyne BD Novolimus Eluting Coronary Stent System receives CE Mark approval

Resuming smoking after stroke can increase risk of mortality

CardioDx completes two-tranche equity financing

Study explores gender-related differences in patients hospitalized for acute heart failure

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Newsletters you may be interested in